Healthcare technology company Premier Inc. announced it will be acquired by Patient Square Capital in a $2.6 billion transaction that will take the supply chain solutions provider private after more than a decade on public markets.
The deal, valued at $28.25 per share in cash, represents a 9.7% premium to Premier's closing price on Friday and nearly 24% premium over the company's 60-day volume-weighted average share price as of September 5. Premier's board unanimously approved the transaction following careful consideration of strategic alternatives and consultation with financial and legal advisors.
Strategic Rationale and Leadership Perspectives
Premier's Board Chair Richard Statuto emphasized the transaction's strategic value, stating the board believes "this transaction is in the best interests of Premier and its stockholders and, upon closing, will deliver immediate and certain value to our stockholders, while simultaneously providing the Company with access to additional capital that can accelerate the support and services provided to members and other customers during this critical time in health care."
CEO Michael J. Alkire highlighted how the transition to private ownership will enhance operational capabilities. "As the health care landscape continues to rapidly evolve, transitioning to private ownership will once again enhance the Company's financial flexibility and provide additional resources to accelerate the advancement and tech-enablement of our product portfolio, capitalize on emerging opportunities and continue pushing the envelope of innovation," Alkire said.
Premier's Healthcare Technology Platform
The Charlotte, North Carolina-based company has been publicly traded on Nasdaq since 2013, offering integrated data analytics, supply chain solutions, consulting services, and collaborative programs designed to improve community health outcomes. Premier works with hospitals, health systems, and other healthcare providers to reduce costs and enhance patient care through coordinated purchasing of equipment and supplies.
Alkire noted that since going public, "Premier has leveraged our access to capital to build unmatched supply chain expertise, world-class technology, and nationally recognized advisory capabilities that enable our members to continuously improve their cost, quality, and operational efficiencies."
Patient Square's Investment Thesis
Patient Square Capital, a dedicated healthcare investment firm, sees significant growth potential in Premier's differentiated service portfolio. Founding Partner Neel Varshney expressed confidence in the acquisition, stating: "We have long admired Premier as an innovator of essential services and products to its members, which are leading institutions and providers in the U.S. health care system. Our team sees tremendous opportunity for Premier to continue growing its differentiated portfolio in supply chain services, data and technology offerings, and consulting solutions that deliver value to patients."
Transaction Timeline and Structure
The acquisition is expected to close by the first quarter of 2026, subject to necessary regulatory approvals and customary closing conditions. Upon completion, Premier will operate as a private company and its common stock will no longer be listed or traded on any public exchange.
The transaction was supported by prominent legal counsel, with Wachtell Lipton Rosen & Katz advising Premier and Cravath Swaine & Moore LLP guiding the transaction committee of Premier's board. Patient Square was represented by Kirkland & Ellis LLP and Ropes & Gray LLP.
